Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category

Search this blog

EMA’s Medical Literature Monitoring: Shakedown or Shakeup

Posted on October 27th, 2015 by Julio dos Anjos in Pharmacovigilance

Although, quite a lot of existing flows have to change and new ones have to be implemented, there are, also, quite a lot of benefits, most of them for EMA, and some, not so obvious, for the MAH’s. Of these last ones, many are found by looking at the information, now made available by EMA, as an information professional in a pharmacovigilance context, as well as a pharmacovigilance analyst in an information rich environment.